Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $220,841 - $258,728
-909 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$236.26 - $355.63 $15,829 - $23,827
-67 Reduced 6.86%
909 $223,000
Q3 2020

Nov 16, 2020

SELL
$264.77 - $305.71 $6.73 Million - $7.77 Million
-25,410 Reduced 96.3%
976 $277,000
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $4.88 Million - $6.47 Million
-18,880 Reduced 41.71%
26,386 $7.06 Million
Q1 2020

May 15, 2020

BUY
$268.85 - $341.04 $58,340 - $74,005
217 Added 0.48%
45,266 $14.3 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $89,124 - $123,148
-405 Reduced 0.89%
45,049 $13.4 Million
Q3 2019

Nov 14, 2019

BUY
$217.44 - $243.88 $13,263 - $14,876
61 Added 0.13%
45,454 $10.6 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $5,043 - $5,559
-23 Reduced 0.05%
45,393 $10.6 Million
Q1 2019

May 15, 2019

BUY
$216.71 - $338.96 $122,657 - $191,851
566 Added 1.26%
45,416 $10.7 Million
Q4 2018

Feb 14, 2019

SELL
$278.5 - $352.75 $352,859 - $446,934
-1,267 Reduced 2.75%
44,850 $13.5 Million
Q3 2018

Nov 14, 2018

BUY
$293.51 - $383.83 $2.44 Million - $3.19 Million
8,310 Added 21.98%
46,117 $16.3 Million
Q2 2018

Aug 14, 2018

SELL
$257.52 - $306.91 $15,966 - $19,028
-62 Reduced 0.16%
37,807 $11 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $60,350 - $85,355
232 Added 0.62%
37,869 $10.4 Million
Q4 2017

Feb 14, 2018

SELL
$307.64 - $344.58 $42,146 - $47,207
-137 Reduced 0.36%
37,637 $12 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $10.6 Million - $12.5 Million
37,774
37,774 $11.8 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Zacks Investment Management Portfolio

Follow Zacks Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.